Posted on 1/3/19
Conduent Completes Acquisition of Health Solutions Plus
Conduent Incorporated (NYSE: CNDT) today announced it has completed its acquisition of Health Solutions Plus (HSP), a software provider of healthcare payer administration solutions.
Posted on 1/3/19
Tragara Pharmaceuticals Appoints Scott Megaffin as Chief Executive Officer and Changes Name to Adastra Pharmaceuticals
Tragara Pharmaceuticals Inc. today announced the appointment of Scott Megaffin as Chief Executive Officer and a member of the Board of Directors effective immediately. Megaffin brings . . .
Posted on 1/3/19
Hackensack Meridian Health and Carrier Clinic Merge
Hackensack Meridian Health, New Jersey's largest and most comprehensive and integrated health network, is proud to announce that Carrier Clinic,
Posted on 1/3/19
Cabaletta Bio Closes $50 Million Series B Financing
Cabaletta Bio Inc., a biotechnology company focused on the discovery and development of T cell therapies for B cell-mediated autoimmune diseases
Posted on 1/3/19
Kashiv Pharma Acquires Adello Biologics and Becomes Kashiv BioSciences
Kashiv Pharma, LLC, a pharmaceutical research and drug delivery company developing next-generation technologies, innovative medicines for patients with unmet medical needs
Posted on 1/3/19
Bristol-Myers Squibb To Acquire Celgene
Bristol-Myers Squibb Company (NYSE:BMY) and Celgene Corporation (NASDAQ:CELG) today announced that they have entered into a definitive merger agreement
Posted on 1/3/19
Teva and Amgen Resolve Ongoing Dispute Over Teva’s Generic Cinacalet HCl Product
PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) announced today that it has resolved its ongoing dispute with Amgen over Teva’s generic cinacalcet HCl . . .
Posted on 1/3/19
Ohr Pharmaceutical and NeuBase Therapeutics To Merge
Ohr Pharmaceutical, Inc. (Nasdaq: OHRP) announced today that it has entered into a definitive merger agreement with NeuBase Therapeutics, Inc.,
Posted on 1/2/19
Hikma Pharmaceutical Plants Sold to Investor Group
Eatontown, New Jersey, Jan. 02, 2019 (GLOBE NEWSWIRE) -- A joint venture between Gordon Brothers and New Mill Capital Holdings has acquired three buildings from Hikma Pharmaceuticals in . . .
Posted on 1/2/19
Luitpold Pharmaceuticals Renamed American Regent
Luitpold Pharmaceuticals, Inc., a manufacturer and distributor of pharmaceuticals that addresses diverse medical and veterinary needs, announced it changed its legal name to American Regent, Inc. . . .
Posted on 1/2/19
White Oak Healthcare Finance Provides $161 Million to Support Allegiant Healthcare’s SNF Acquisition
NEW YORK--(BUSINESS WIRE)--White Oak Healthcare Finance, LLC, today announced it acted as sole lender and administrative agent on the funding of a $161 million senior credit . . .
Posted on 1/2/19
Consonance Capital Partners Completes Recapitalization of Psychiatric Medical Care
NEW YORK & NASHVILLE, Tenn.--(BUSINESS WIRE)--Consonance Capital Partners, a leading healthcare-focused private equity fund announced today that it completed the recapitalization of Psychiatric Medical Care, LLC . . .
Posted on 1/1/19
Immunomedics and Johnson Matthey Announce Strategic Manufacturing Partnership
MORRIS PLAINS, N.J. and DEVENS, Mass., Dec. 26, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (NASDAQ: IMMU) and Johnson Matthey (LSE: JMAT), today announced the companies have . . .
Posted on 12/21/18
Pfizer: Consumer Health Deal Looks Good
SummaryPfizer is combining its consumer business unit in a smart deal with that of GSK.I like the deal which looks smart but is too small to . . .
Posted on 12/21/18
Johnson & Johnson: Buy The Dip? A 2-Point Analysis
SummaryJNJ shares were doing well this year as investors bought Big Pharma, then got hit on a Reuters article.I have reviewed JNJ's product liability issues before . . .
Posted on 12/21/18
Pfizer: Steady As She Goes
SummaryIf the sell-off continues, we are looking for strong support at the 200 dma.Dividend gets hiked by 6%.We see more mid increases coming.Looking for a portfolio . . .
Posted on 12/21/18
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on December 17, 2018 it approved non-statutory stock options to purchase an aggregate of 24,500 shares of its . . .
Posted on 12/20/18
Johnson & Johnson: Caution Here
SummaryJohnson & Johnson has seen harsh times as an old asbestos claim is playing up again.Shares have been hit hard as this times it looks serious, . . .
Posted on 12/20/18
Why I Had To Buy Johnson & Johnson
SummaryJohnson & Johnson is truly one of the most beloved dividend growth stocks and a cornerstone of many portfolios.The story from Reuters alleging the presence of . . .
Posted on 12/20/18
Johnson & Johnson: Weak Sign
Summary JNJ continues to face escalating liability risk due to talc cancer lawsuits. The authorized $5 billion share buyback reduces confidence in the stock. Even after . . .
Posted on 12/20/18
Generic Electric: Healthcare IPO May Not Avert A Junk Rating
Summary GE is looking to sell a stake in Healthcare to help pare debt. GE's debt/EBITDA is 7.0x, which would be considered below investment grade. GE . . .
Posted on 12/20/18
Merck To Acquire Antelliq Group For Animal Monitoring Tech
Merck (MRK) announced it has agreed to acquire Antelliq Group for $3.72 billion in total consideration and debt assumption.
Posted on 12/20/18
Teladoc Health: Down But Not Out
SummaryTeladoc Health's stock is down big over the last three months.And the recent departure of Teladoc Health's Chief Operating Officer/Chief Financial Officer added fuel to the . . .
Posted on 12/20/18
Melinta Therapeutics Announces Commitment for New Credit Facility of Up to $135 Million
NEW HAVEN, Conn., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial . . .
Posted on 12/19/18
ADMA Biologics Provides Regulatory Update for BIVIGAM
RAMSEY, N.J. and BOCA RATON, Fla., Dec. 19, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA), announces that as of the time of this press . . .

